Person · CIK 1612451
Quentin S. Blackford
Director at Align Technology, Alphatec Holdings and Paragon 28; President and CEO at iRhythm Holdings
Earlier: Axogen, Dexcom and Nuvasive
Sold on Form 4$62.9M
Noticed on Form 144$4.8M
Bought on Form 4$1.5M
Companies7
Holdings now
As reported after the latest Form 3, 4 or 5 at each company.
How these figures work
Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.
| Company | Security | Held | Shares or units | As of |
|---|---|---|---|---|
| Align Technology ALGN | Restricted Stock Units into Common Stock | Directly | 1,376 | Aug 27, 2026 · Filing · EDGAR |
| iRhythm Holdings IRTC | Common Stock | Directly | 226,008 | Aug 10, 2026 · Filing · EDGAR |
| Alphatec Holdings ATEC | Common Stock | Directly | 600,381 | Jun 10, 2026 · Filing · EDGAR |
| Axogen | Common Stock | Directly | 27,335 | Mar 30, 2022 · Filing · EDGAR |
| Dexcom | Common Stock | Directly | 19,280 | Sep 10, 2021 · Filing · EDGAR |
| Nuvasive | Common Stock | Directly | 21,004 | Feb 1, 2017 · Filing · EDGAR |
| Nuvasive | PRSUs into Common Stock | Directly | 13,203 | Feb 8, 2017 · Filing · EDGAR |
Sold and noticed by quarter
Sold (Form 4) Noticed (Form 144) Bought (Form 4)
Quarterly totals as a table
| Quarter | Sold (Form 4) | Noticed (Form 144) | Bought (Form 4) |
|---|---|---|---|
| Q3 2026 | $3.3M | — | — |
| Q1 2026 | $5.2M | — | — |
| Q4 2025 | $2.6M | — | — |
| Q3 2025 | $4.8M | $4.8M | — |
| Q1 2025 | $3.4M | — | — |
| Q4 2024 | $1.2M | — | — |
| Q1 2024 | $3.5M | — | $257K |
| Q2 2023 | — | — | $998K |
| Q4 2022 | $1.6M | Not machine-readable | — |
| Q3 2021 | $10.2M | Not machine-readable | — |
| Q2 2021 | $2.7M | Not machine-readable | — |
| Q1 2021 | $2.4M | Not machine-readable | — |
| Q3 2020 | $10M | Not machine-readable | — |
| Q1 2020 | $3.4M | Not machine-readable | — |
| Q3 2019 | $3.2M | Not machine-readable | $218K |
| Q2 2019 | $1.1M | Not machine-readable | — |
| Q1 2019 | $765K | Not machine-readable | — |
| Q3 2018 | $2.3M | Not machine-readable | — |
| Q4 2015 | $767K | Not machine-readable | — |
| Q4 2014 | $516K | Not machine-readable | — |
Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.
Planned sales (Form 144) and the sales that followed
Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.
How we match
A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.
| Notice date | Noticed | Planned sale | Outcome | Links |
|---|---|---|---|---|
| iRhythm Holdings IRTC · Morgan Stanley Smith Barney · 10b5-1 plan adopted May 5, 2025 · 1 notice | ||||
| Aug 5, 2025 | 30,000 · ~$4.8M | Aug 5, 2025 | Sold as noticed Sold 30,000 in 7 sales, Aug 5 to Aug 5 · $4.8M Form 4 | Filing · EDGAR |
| Sales without a matching Form 144 · 79 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt. | ||||
| — | — | — | Sold without notice iRhythm Holdings (IRTC): Sold 26,859 at $124.65 on Aug 10, 2026 · $3.3M | Filing · EDGAR |
| — | — | — | Sold without notice iRhythm Holdings (IRTC): Sold 5,423 at $128.44 on Mar 2, 2026 · $697K | Filing · EDGAR |
| — | — | — | Sold without notice iRhythm Holdings (IRTC): Sold 4,043 at $128.44 on Mar 2, 2026 · $519K | Filing · EDGAR |
| — | — | — | Sold without notice iRhythm Holdings (IRTC): Sold 4,347 at $128.44 on Mar 2, 2026 · $558K | Filing · EDGAR |
| — | — | — | Sold without notice iRhythm Holdings (IRTC): Sold 25,540 at $135.42 on Feb 25, 2026 · $3.5M | Filing · EDGAR |
| — | — | — | Sold without notice iRhythm Holdings (IRTC): Sold 14,059 at $182.94 on Nov 3, 2025 · $2.6M | Filing · EDGAR |
| — | — | — | Sold without notice iRhythm Holdings (IRTC): Sold 8,145 at $108.77 on Mar 3, 2025 · $886K | Filing · EDGAR |
| — | — | — | Sold without notice iRhythm Holdings (IRTC): Sold 22,252 at $112.13 on Feb 26, 2025 · $2.5M | Filing · EDGAR |
| — | — | — | Sold without notice iRhythm Holdings (IRTC): Sold 16,145 at $77.41 on Nov 4, 2024 · $1.2M | Filing · EDGAR |
| — | — | — | Sold without notice iRhythm Holdings (IRTC): Sold 4,221 at $111.14 on Mar 4, 2024 · $469K | Filing · EDGAR |
| — | — | — | Sold without notice iRhythm Holdings (IRTC): Sold 24,701 at $121.96 on Feb 29, 2024 · $3M | Filing · EDGAR |
| — | — | — | Notice not machine-readable iRhythm Holdings (IRTC): Sold 12,415 at $122.50 on Nov 2, 2022 · $1.5M | Filing · EDGAR |
| — | — | — | Notice not machine-readable iRhythm Holdings (IRTC): Sold 284 at $118.17 on Nov 2, 2022 · $34K | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 1,519 at $558.33 on Sep 10, 2021 · $848K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 200 at $551.28 on Sep 9, 2021 · $110K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 2,200 at $550.51 on Sep 9, 2021 · $1.2M (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 2,394 at $549.45 on Sep 9, 2021 · $1.3M (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 1,200 at $548.40 on Sep 9, 2021 · $658K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 900 at $547.28 on Sep 9, 2021 · $493K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 100 at $545.10 on Sep 9, 2021 · $55K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 100 at $543.66 on Sep 9, 2021 · $54K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 300 at $542.83 on Sep 9, 2021 · $163K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 515 at $541.45 on Sep 9, 2021 · $279K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 19 at $542.03 on Sep 9, 2021 · $10K | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 1,534 at $541.36 on Sep 9, 2021 · $830K | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 42 at $546.31 on Sep 8, 2021 · $23K | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 7,639 at $545.87 on Sep 8, 2021 · $4.2M | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 7,223 at $375.00 on May 28, 2021 · $2.7M (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 6,509 at $362.22 on Mar 10, 2021 · $2.4M | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 171 at $405.33 on Sep 10, 2020 · $69K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 272 at $403.87 on Sep 10, 2020 · $110K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 2,159 at $402.72 on Sep 10, 2020 · $869K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 3,157 at $401.79 on Sep 10, 2020 · $1.3M (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 3,017 at $399.91 on Sep 10, 2020 · $1.2M (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 1,594 at $398.98 on Sep 10, 2020 · $636K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 1,300 at $397.76 on Sep 10, 2020 · $517K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 523 at $397.03 on Sep 10, 2020 · $208K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 1,579 at $398.30 on Sep 9, 2020 · $629K | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 3,297 at $398.30 on Sep 9, 2020 · $1.3M | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 8,010 at $398.30 on Sep 9, 2020 · $3.2M | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 100 at $244.78 on Mar 12, 2020 · $24K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 400 at $244.01 on Mar 12, 2020 · $98K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 500 at $241.06 on Mar 12, 2020 · $121K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 1,100 at $239.63 on Mar 12, 2020 · $264K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 600 at $238.29 on Mar 12, 2020 · $143K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 641 at $237.10 on Mar 12, 2020 · $152K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 472 at $235.90 on Mar 12, 2020 · $111K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 300 at $234.23 on Mar 12, 2020 · $70K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 200 at $232.00 on Mar 12, 2020 · $46K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 200 at $228.86 on Mar 12, 2020 · $46K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 400 at $227.56 on Mar 12, 2020 · $91K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 457 at $223.62 on Mar 12, 2020 · $102K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 200 at $220.50 on Mar 12, 2020 · $44K | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 200 at $219.37 on Mar 12, 2020 · $44K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 583 at $218.84 on Mar 12, 2020 · $128K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 5,963 at $265.43 on Mar 11, 2020 · $1.6M | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 129 at $251.03 on Mar 11, 2020 · $32K | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 116 at $246.61 on Mar 11, 2020 · $29K | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 891 at $261.00 on Mar 9, 2020 · $233K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 600 at $144.57 on Sep 10, 2019 · $87K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 406 at $143.57 on Sep 10, 2019 · $58K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 1,289 at $142.16 on Sep 10, 2019 · $183K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 3,725 at $141.62 on Sep 10, 2019 · $528K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 2,500 at $140.47 on Sep 10, 2019 · $351K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 1,800 at $139.29 on Sep 10, 2019 · $251K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 11,049 at $150.11 on Sep 9, 2019 · $1.7M | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 637 at $145.45 on Sep 9, 2019 · $93K | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 3,376 at $119.30 on May 29, 2019 · $403K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 5,498 at $118.73 on May 29, 2019 · $653K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 5,358 at $142.79 on Mar 12, 2019 · $765K | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 3,680 at $148.22 on Sep 11, 2018 · $545K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 1,460 at $147.41 on Sep 11, 2018 · $215K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 1,200 at $146.15 on Sep 11, 2018 · $175K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 2,100 at $145.23 on Sep 11, 2018 · $305K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Dexcom: Sold 7,149 at $143.76 on Sep 10, 2018 · $1M | Filing · EDGAR |
| — | — | — | Notice not machine-readable Nuvasive: Sold 15,000 at $51.10 on Dec 7, 2015 · $767K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Nuvasive: Sold 678 at $43.78 on Nov 19, 2014 · $30K (10b5-1 plan) | Filing · EDGAR |
| — | — | — | Notice not machine-readable Nuvasive: Sold 7,020 at $43.38 on Nov 19, 2014 · $304K | Filing · EDGAR |
| — | — | — | Notice not machine-readable Nuvasive: Sold 5,000 at $36.30 on Oct 3, 2014 · $182K (10b5-1 plan) | Filing · EDGAR |
Every transaction, by company
Each Form 3, 4 and 5 transaction in plain words, newest first.
How these figures work
Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.
iRhythm Holdings IRTC President and CEO · filings 2021 to 2026 · sold $25.6M · bought $998K · $4.8M noticed on Form 144
| Date | Transaction | Shares | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Open-market or private sale | −26,859 | $124.65 | $3.3M | 226,008 direct | Filing · EDGAR |
| Aug 7, 2026 | Grant or award from the company | +48,534 | 252,867 direct | Filing · EDGAR | ||
| May 29, 2026 | Grant or award from the company | +178 | $96.82 | $17K | 204,333 direct | Filing · EDGAR |
| Mar 2, 2026 | Open-market or private sale | −4,347 | $128.44 | $558K | 213,621 direct | Filing · EDGAR |
| Mar 2, 2026 | Open-market or private sale | −4,043 | $128.44 | $519K | 209,578 direct | Filing · EDGAR |
| Mar 2, 2026 | Open-market or private sale | −5,423 | $128.44 | $697K | 204,155 direct | Filing · EDGAR |
| Feb 25, 2026 | Grant or award from the company | +31,842 | 217,968 direct | Filing · EDGAR | ||
| Feb 25, 2026 | Open-market or private sale | −25,540 | $135.42 | $3.5M | 186,126 direct | Filing · EDGAR |
| Feb 24, 2026 | Grant or award from the company | +46,687 | 211,666 direct | Filing · EDGAR | ||
| Nov 3, 2025 | Open-market or private sale | −14,059 | $182.94 | $2.6M | 164,979 direct | Filing · EDGAR |
| Aug 5, 2025 | Sale under a 10b5-1 plan | −8,726 | $158.85 | $1.4M | 200,312 direct | Filing · EDGAR |
| Aug 5, 2025 | Sale under a 10b5-1 plan | −9,775 | $160.06 | $1.6M | 190,537 direct | Filing · EDGAR |
| Aug 5, 2025 | Sale under a 10b5-1 plan | −4,905 | $160.73 | $788K | 185,632 direct | Filing · EDGAR |
| Aug 5, 2025 | Sale under a 10b5-1 plan | −1,600 | $161.92 | $259K | 184,032 direct | Filing · EDGAR |
| Aug 5, 2025 | Sale under a 10b5-1 plan | −1,514 | $163.30 | $247K | 182,518 direct | Filing · EDGAR |
| Aug 5, 2025 | Sale under a 10b5-1 plan | −3,174 | $163.93 | $520K | 179,344 direct | Filing · EDGAR |
| Aug 5, 2025 | Sale under a 10b5-1 plan | −306 | $165.00 | $50K | 179,038 direct | Filing · EDGAR |
| May 30, 2025 | Grant or award from the company | +297 | $71.46 | $21K | 209,038 direct | Filing · EDGAR |
| Mar 3, 2025 | Open-market or private sale | −8,145 | $108.77 | $886K | 208,741 direct | Filing · EDGAR |
| Feb 26, 2025 | Grant or award from the company | +38,599 | 239,138 direct | Filing · EDGAR | ||
| Feb 26, 2025 | Open-market or private sale | −22,252 | $112.13 | $2.5M | 216,886 direct | Filing · EDGAR |
| Feb 25, 2025 | Grant or award from the company | +40,610 | 200,539 direct | Filing · EDGAR | ||
| Nov 4, 2024 | Open-market or private sale | −16,145 | $77.41 | $1.2M | 159,929 direct | Filing · EDGAR |
| May 31, 2024 | Grant or award from the company | +280 | $74.98 | $21K | 176,074 direct | Filing · EDGAR |
| Mar 4, 2024 | Open-market or private sale | −4,221 | $111.14 | $469K | 175,794 direct | Filing · EDGAR |
| Feb 29, 2024 | Open-market or private sale | −24,701 | $121.96 | $3M | 180,015 direct | Filing · EDGAR |
| Feb 28, 2024 | Grant or award from the company | +30,938 | 204,716 direct | Filing · EDGAR | ||
| Feb 27, 2024 | Grant or award from the company | +45,268 | 173,778 direct | Filing · EDGAR | ||
| Jun 6, 2023 | Open-market or private purchase | +9,755 | $102.27 | $998K | 128,510 direct | Filing · EDGAR |
| Jun 6, 2023 | Grant or award from the company | +9,755 | $102.27 | $998K | 128,510 direct | Filing · EDGAR |
| Feb 27, 2023 | Grant or award from the company | +28,775 | 118,524 direct | Filing · EDGAR | ||
| Nov 2, 2022 | Open-market or private sale | −284 | $118.17 | $34K | 101,695 direct | Filing · EDGAR |
| Nov 2, 2022 | Open-market or private sale | −12,415 | $122.50 | $1.5M | 89,280 direct | Filing · EDGAR |
| Oct 5, 2021 | Grant or award from the company | +101,979 | 101,979 direct | Filing · EDGAR |
Alphatec Holdings ATEC Director · filings 2017 to 2026 · bought $257K
| Date | Transaction | Shares | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | Grant or award from the company | +32,012 | 600,381 direct | Filing · EDGAR | ||
| Jun 11, 2025 | Grant or award from the company | +15,131 | 568,369 direct | Filing · EDGAR | ||
| May 5, 2025 | Gift | −21,000 | 553,238 direct | Filing · EDGAR | ||
| Nov 21, 2024 | Gift | −15,114 | 574,238 direct | Filing · EDGAR | ||
| Jun 12, 2024 | Grant or award from the company | +16,747 | 589,352 direct | Filing · EDGAR | ||
| Mar 7, 2024 | Open-market or private purchase | +20,000 | $12.83 | $257K | 572,605 direct | Filing · EDGAR |
| Jun 20, 2023 | Grant or award from the company | +9,908 | 552,605 direct | Filing · EDGAR | ||
| Jun 15, 2022 | Grant or award from the company | +18,546 | 542,697 direct | Filing · EDGAR | ||
| Jun 16, 2021 | Grant or award from the company | +10,221 | 524,151 direct | Filing · EDGAR | ||
| Nov 3, 2020 | Gift | −16,250 | 513,930 direct | Filing · EDGAR | ||
| Jun 17, 2020 | Grant or award from the company | +28,013 | 530,180 direct | Filing · EDGAR | ||
| Jun 21, 2019 | Grant or award from the company | +18,086 | 502,167 direct | Filing · EDGAR | ||
| Jul 30, 2018 | Grant or award from the company | +20,492 | 462,970 direct | Filing · EDGAR | ||
| Jul 30, 2018 | Grant or award from the company | +21,111 | 484,081 direct | Filing · EDGAR | ||
| Dec 28, 2017 | Grant or award from the company | +442,478 | $2.26 | $1M | 442,478 direct | Filing · EDGAR |
Paragon 28 FNA Director · filings 2022 to 2025
| Date | Transaction | Shares | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|
| Apr 21, 2025 | Returned to the company | −50,554 | 0 direct | Filing · EDGAR | ||
| May 17, 2024 | Grant or award from the company | +15,906 | 50,554 direct | Filing · EDGAR | ||
| May 17, 2023 | Grant or award from the company | +8,361 | 34,648 direct | Filing · EDGAR | ||
| Aug 1, 2022 | Grant or award from the company | +16,287 | $18.42 | $300K | 16,287 direct | Filing · EDGAR |
Axogen Director · filings 2019 to 2022 · bought $218K
| Date | Transaction | Shares | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|
| Mar 30, 2022 | Option or RSU exercised or converted | +3,036 | 27,335 direct | Filing · EDGAR | ||
| Mar 30, 2022 | Option or RSU exercised or converted Restricted Stock Units | −3,036 | 0 direct | Filing · EDGAR | ||
| Jun 1, 2021 | Option or RSU exercised or converted | +6,173 | 24,299 direct | Filing · EDGAR | ||
| Jun 1, 2021 | Option or RSU exercised or converted Restricted Stock Units | −6,173 | 0 direct | Filing · EDGAR | ||
| Jun 1, 2021 | Grant or award from the company Stock Option (right to purchase) | +6,030 | 6,030 direct | Filing · EDGAR | ||
| Jun 1, 2021 | Grant or award from the company Restricted Stock Units | +3,036 | 3,036 direct | Filing · EDGAR | ||
| Sep 3, 2020 | Grant or award from the company | +2,591 | $11.75 | $30K | 18,126 direct | Filing · EDGAR |
| Jun 1, 2020 | Grant or award from the company Stock Option (right to purchase) | +12,605 | 12,605 direct | Filing · EDGAR | ||
| Jun 1, 2020 | Grant or award from the company Restricted Stock Units | +6,173 | 6,173 direct | Filing · EDGAR | ||
| Sep 3, 2019 | Grant or award from the company Stock Option (right to purchase) | +10,710 | 10,710 direct | Filing · EDGAR | ||
| Sep 3, 2019 | Grant or award from the company Restricted Stock Units | +2,591 | 2,591 direct | Filing · EDGAR | ||
| Aug 12, 2019 | Open-market or private purchase | +14,170 | $14.10 | $200K | 15,535 direct | Filing · EDGAR |
| Aug 9, 2019 | Open-market or private purchase | +1,165 | $13.10 | $15K | 1,165 direct | Filing · EDGAR |
| Aug 9, 2019 | Open-market or private purchase | +200 | $13.07 | $3K | 1,365 direct | Filing · EDGAR |
| May 15, 2019 | Grant or award from the company Stock Option (right to purchase) | +23,933 | 23,933 direct | Filing · EDGAR |
Dexcom Chief Operating Officer · filings 2017 to 2021 · sold $36M
| Date | Transaction | Shares | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|
| Sep 10, 2021 | Sale under a 10b5-1 plan | −1,519 | $558.33 | $848K | 19,280 direct | Filing · EDGAR |
| Sep 9, 2021 | Open-market or private sale | −1,534 | $541.36 | $830K | 28,727 direct | Filing · EDGAR |
| Sep 9, 2021 | Open-market or private sale | −19 | $542.03 | $10K | 28,708 direct | Filing · EDGAR |
| Sep 9, 2021 | Sale under a 10b5-1 plan | −515 | $541.45 | $279K | 28,193 direct | Filing · EDGAR |
| Sep 9, 2021 | Sale under a 10b5-1 plan | −300 | $542.83 | $163K | 27,893 direct | Filing · EDGAR |
| Sep 9, 2021 | Sale under a 10b5-1 plan | −100 | $543.66 | $54K | 27,793 direct | Filing · EDGAR |
| Sep 9, 2021 | Sale under a 10b5-1 plan | −100 | $545.10 | $55K | 27,693 direct | Filing · EDGAR |
| Sep 9, 2021 | Sale under a 10b5-1 plan | −900 | $547.28 | $493K | 26,793 direct | Filing · EDGAR |
| Sep 9, 2021 | Sale under a 10b5-1 plan | −1,200 | $548.40 | $658K | 25,593 direct | Filing · EDGAR |
| Sep 9, 2021 | Sale under a 10b5-1 plan | −2,394 | $549.45 | $1.3M | 23,199 direct | Filing · EDGAR |
| Sep 9, 2021 | Sale under a 10b5-1 plan | −2,200 | $550.51 | $1.2M | 20,999 direct | Filing · EDGAR |
| Sep 9, 2021 | Sale under a 10b5-1 plan | −200 | $551.28 | $110K | 20,799 direct | Filing · EDGAR |
| Sep 8, 2021 | Open-market or private sale | −7,639 | $545.87 | $4.2M | 30,303 direct | Filing · EDGAR |
| Sep 8, 2021 | Open-market or private sale | −42 | $546.31 | $23K | 30,261 direct | Filing · EDGAR |
| May 28, 2021 | Sale under a 10b5-1 plan | −7,223 | $375.00 | $2.7M | 37,942 direct | Filing · EDGAR |
| Mar 10, 2021 | Open-market or private sale | −6,509 | $362.22 | $2.4M | 45,165 direct | Filing · EDGAR |
| Mar 8, 2021 | Grant or award from the company | +7,491 | $0.00 | $7 | 51,674 direct | Filing · EDGAR |
| Sep 10, 2020 | Sale under a 10b5-1 plan | −523 | $397.03 | $208K | 55,794 direct | Filing · EDGAR |
| Sep 10, 2020 | Sale under a 10b5-1 plan | −1,300 | $397.76 | $517K | 54,494 direct | Filing · EDGAR |
| Sep 10, 2020 | Sale under a 10b5-1 plan | −1,594 | $398.98 | $636K | 52,900 direct | Filing · EDGAR |
| Sep 10, 2020 | Sale under a 10b5-1 plan | −3,017 | $399.91 | $1.2M | 49,883 direct | Filing · EDGAR |
| Sep 10, 2020 | Sale under a 10b5-1 plan | −3,157 | $401.79 | $1.3M | 46,726 direct | Filing · EDGAR |
| Sep 10, 2020 | Sale under a 10b5-1 plan | −2,159 | $402.72 | $869K | 44,567 direct | Filing · EDGAR |
| Sep 10, 2020 | Sale under a 10b5-1 plan | −272 | $403.87 | $110K | 44,295 direct | Filing · EDGAR |
| Sep 10, 2020 | Sale under a 10b5-1 plan | −171 | $405.33 | $69K | 44,124 direct | Filing · EDGAR |
| Sep 9, 2020 | Open-market or private sale | −8,010 | $398.30 | $3.2M | 61,193 direct | Filing · EDGAR |
| Sep 9, 2020 | Open-market or private sale | −3,297 | $398.30 | $1.3M | 57,896 direct | Filing · EDGAR |
| Sep 9, 2020 | Open-market or private sale | −1,579 | $398.30 | $629K | 56,317 direct | Filing · EDGAR |
| Mar 12, 2020 | Sale under a 10b5-1 plan | −583 | $218.84 | $128K | 74,973 direct | Filing · EDGAR |
| Mar 12, 2020 | Sale under a 10b5-1 plan | −200 | $219.37 | $44K | 74,773 direct | Filing · EDGAR |
| Mar 12, 2020 | Open-market or private sale | −200 | $220.50 | $44K | 74,573 direct | Filing · EDGAR |
| Mar 12, 2020 | Sale under a 10b5-1 plan | −457 | $223.62 | $102K | 74,116 direct | Filing · EDGAR |
| Mar 12, 2020 | Sale under a 10b5-1 plan | −400 | $227.56 | $91K | 73,716 direct | Filing · EDGAR |
| Mar 12, 2020 | Sale under a 10b5-1 plan | −200 | $228.86 | $46K | 73,516 direct | Filing · EDGAR |
| Mar 12, 2020 | Sale under a 10b5-1 plan | −200 | $232.00 | $46K | 73,316 direct | Filing · EDGAR |
| Mar 12, 2020 | Sale under a 10b5-1 plan | −300 | $234.23 | $70K | 73,016 direct | Filing · EDGAR |
| Mar 12, 2020 | Sale under a 10b5-1 plan | −472 | $235.90 | $111K | 72,544 direct | Filing · EDGAR |
| Mar 12, 2020 | Sale under a 10b5-1 plan | −641 | $237.10 | $152K | 71,903 direct | Filing · EDGAR |
| Mar 12, 2020 | Sale under a 10b5-1 plan | −600 | $238.29 | $143K | 71,303 direct | Filing · EDGAR |
| Mar 12, 2020 | Sale under a 10b5-1 plan | −1,100 | $239.63 | $264K | 70,203 direct | Filing · EDGAR |
| Mar 12, 2020 | Sale under a 10b5-1 plan | −500 | $241.06 | $121K | 69,703 direct | Filing · EDGAR |
| Mar 12, 2020 | Sale under a 10b5-1 plan | −400 | $244.01 | $98K | 69,303 direct | Filing · EDGAR |
| Mar 12, 2020 | Sale under a 10b5-1 plan | −100 | $244.78 | $24K | 69,203 direct | Filing · EDGAR |
| Mar 11, 2020 | Open-market or private sale | −116 | $246.61 | $29K | 81,648 direct | Filing · EDGAR |
| Mar 11, 2020 | Open-market or private sale | −129 | $251.03 | $32K | 81,519 direct | Filing · EDGAR |
| Mar 11, 2020 | Open-market or private sale | −5,963 | $265.43 | $1.6M | 75,556 direct | Filing · EDGAR |
| Mar 9, 2020 | Sale under a 10b5-1 plan | −891 | $261.00 | $233K | 81,764 direct | Filing · EDGAR |
| Mar 8, 2020 | Grant or award from the company | +12,727 | $0.00 | $13 | 82,655 direct | Filing · EDGAR |
| Sep 10, 2019 | Sale under a 10b5-1 plan | −1,800 | $139.29 | $251K | 78,274 direct | Filing · EDGAR |
| Sep 10, 2019 | Sale under a 10b5-1 plan | −2,500 | $140.47 | $351K | 75,774 direct | Filing · EDGAR |
| Sep 10, 2019 | Sale under a 10b5-1 plan | −3,725 | $141.62 | $528K | 72,049 direct | Filing · EDGAR |
| Sep 10, 2019 | Sale under a 10b5-1 plan | −1,289 | $142.16 | $183K | 70,760 direct | Filing · EDGAR |
| Sep 10, 2019 | Sale under a 10b5-1 plan | −406 | $143.57 | $58K | 70,354 direct | Filing · EDGAR |
| Sep 10, 2019 | Sale under a 10b5-1 plan | −600 | $144.57 | $87K | 69,754 direct | Filing · EDGAR |
| Sep 9, 2019 | Open-market or private sale | −637 | $145.45 | $93K | 91,123 direct | Filing · EDGAR |
| Sep 9, 2019 | Open-market or private sale | −11,049 | $150.11 | $1.7M | 80,074 direct | Filing · EDGAR |
| May 29, 2019 | Sale under a 10b5-1 plan | −5,498 | $118.73 | $653K | 95,116 direct | Filing · EDGAR |
| May 29, 2019 | Sale under a 10b5-1 plan | −3,376 | $119.30 | $403K | 91,740 direct | Filing · EDGAR |
| Mar 12, 2019 | Open-market or private sale | −5,358 | $142.79 | $765K | 100,614 direct | Filing · EDGAR |
| Mar 8, 2019 | Grant or award from the company | +18,432 | $0.00 | $18 | 105,972 direct | Filing · EDGAR |
7 earlier transactions are in the filing list below.
Nuvasive CFO · filings 2014 to 2017 · sold $1.3M
| Date | Transaction | Shares | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|
| Feb 8, 2017 | Grant or award from the company PRSUs | +13,203 | 13,203 direct | Filing · EDGAR | ||
| Feb 1, 2017 | Option or RSU exercised or converted | +5,339 | 21,078 direct | Filing · EDGAR | ||
| Feb 1, 2017 | Option or RSU exercised or converted | +3,192 | 24,270 direct | Filing · EDGAR | ||
| Feb 1, 2017 | Shares withheld for tax or exercise price | −3,266 | $70.76 | $231K | 21,004 direct | Filing · EDGAR |
| Feb 1, 2017 | Option or RSU exercised or converted RSUs | −5,339 | 0 direct | Filing · EDGAR | ||
| Feb 1, 2017 | Option or RSU exercised or converted PRSUs | −3,192 | 6,384 direct | Filing · EDGAR | ||
| Jan 1, 2017 | Option or RSU exercised or converted | +5,924 | 19,332 direct | Filing · EDGAR | ||
| Jan 1, 2017 | Shares withheld for tax or exercise price | −3,593 | $67.36 | $242K | 15,739 direct | Filing · EDGAR |
| Jan 1, 2017 | Option or RSU exercised or converted RSUs | −5,924 | 5,924 direct | Filing · EDGAR | ||
| Aug 4, 2016 | Gift | −558 | 13,408 direct | Filing · EDGAR | ||
| Aug 3, 2016 | Gift | −319 | 13,966 direct | Filing · EDGAR | ||
| Jul 1, 2016 | Option or RSU exercised or converted | +3,125 | 15,915 direct | Filing · EDGAR | ||
| Jul 1, 2016 | Shares withheld for tax or exercise price | −1,630 | $59.97 | $98K | 14,285 direct | Filing · EDGAR |
| Jul 1, 2016 | Option or RSU exercised or converted RSUs | −3,125 | 0 direct | Filing · EDGAR | ||
| Feb 1, 2016 | Option or RSU exercised or converted | +1,250 | 7,427 direct | Filing · EDGAR | ||
| Feb 1, 2016 | Option or RSU exercised or converted | +5,339 | 12,766 direct | Filing · EDGAR | ||
| Feb 1, 2016 | Option or RSU exercised or converted | +3,193 | 15,959 direct | Filing · EDGAR | ||
| Feb 1, 2016 | Shares withheld for tax or exercise price | −3,674 | $46.60 | $171K | 12,285 direct | Filing · EDGAR |
| Feb 1, 2016 | Option or RSU exercised or converted RSUs | −1,250 | 0 direct | Filing · EDGAR | ||
| Feb 1, 2016 | Option or RSU exercised or converted RSUs | −5,339 | 5,339 direct | Filing · EDGAR | ||
| Jan 26, 2016 | Option or RSU exercised or converted PRSUs | −3,193 | 9,576 direct | Filing · EDGAR | ||
| Jan 26, 2016 | Grant or award from the company PRSUs | +12,769 | 12,769 direct | Filing · EDGAR | ||
| Jan 1, 2016 | Grant or award from the company | +5,924 | 8,523 direct | Filing · EDGAR | ||
| Jan 1, 2016 | Shares withheld for tax or exercise price | −2,346 | $54.11 | $127K | 6,177 direct | Filing · EDGAR |
| Dec 7, 2015 | Sale under a 10b5-1 plan | −15,000 | $51.10 | $767K | 2,599 direct | Filing · EDGAR |
| Oct 1, 2015 | Grant or award from the company | +5,000 | 20,564 direct | Filing · EDGAR | ||
| Oct 1, 2015 | Shares withheld for tax or exercise price | −2,965 | $48.88 | $145K | 17,599 direct | Filing · EDGAR |
| Jul 1, 2015 | Grant or award from the company | +3,125 | 16,827 direct | Filing · EDGAR | ||
| Jul 1, 2015 | Shares withheld for tax or exercise price | −1,263 | $47.52 | $60K | 15,564 direct | Filing · EDGAR |
| Jan 1, 2015 | Grant or award from the company | +3,125 | 3,925 direct | Filing · EDGAR | ||
| Jan 1, 2015 | Shares withheld for tax or exercise price | −1,321 | $47.16 | $62K | 2,604 direct | Filing · EDGAR |
| Jan 1, 2015 | Grant or award from the company | +5,925 | 8,529 direct | Filing · EDGAR | ||
| Jan 1, 2015 | Shares withheld for tax or exercise price | −2,216 | $47.16 | $105K | 6,313 direct | Filing · EDGAR |
| Nov 19, 2014 | Open-market or private sale | −7,020 | $43.38 | $304K | 800 direct | Filing · EDGAR |
| Nov 19, 2014 | Sale under a 10b5-1 plan | −678 | $43.78 | $30K | 800 direct | Filing · EDGAR |
| Nov 18, 2014 | Option or RSU exercised or converted | +7,020 | $29.95 | $210K | 7,820 direct | Filing · EDGAR |
| Nov 18, 2014 | Option or RSU exercised or converted | +4,438 | $29.95 | $133K | 5,238 direct | Filing · EDGAR |
| Nov 18, 2014 | Shares withheld for tax or exercise price | −3,760 | $43.97 | $165K | 1,478 direct | Filing · EDGAR |
| Nov 18, 2014 | Option or RSU exercised or converted Employee Stock Option (Right to Buy) | −7,020 | 0 direct | Filing · EDGAR | ||
| Nov 18, 2014 | Option or RSU exercised or converted Employee Stock Option (Right to Buy) | −4,438 | 0 direct | Filing · EDGAR | ||
| Oct 3, 2014 | Sale under a 10b5-1 plan | −5,000 | $36.30 | $182K | 12,902 direct | Filing · EDGAR |
All 85 Forms 3, 4, 5 and 144
| Filed | Form | Company | Links |
|---|---|---|---|
| Aug 31, 2026 | Form 4 | Align Technology ALGN | Filing · EDGAR |
| Aug 31, 2026 | Form 3 | Align Technology ALGN | Filing · EDGAR |
| Aug 11, 2026 | Form 4 | iRhythm Holdings IRTC | Filing · EDGAR |
| Jun 12, 2026 | Form 4 | Alphatec Holdings ATEC | Filing · EDGAR |
| Jun 1, 2026 | Form 4 | iRhythm Holdings IRTC | Filing · EDGAR |
| Mar 3, 2026 | Form 4 | iRhythm Holdings IRTC | Filing · EDGAR |
| Feb 27, 2026 | Form 4 | iRhythm Holdings IRTC | Filing · EDGAR |
| Feb 26, 2026 | Form 4 | iRhythm Holdings IRTC | Filing · EDGAR |
| Nov 4, 2025 | Form 4 | iRhythm Holdings IRTC | Filing · EDGAR |
| Aug 6, 2025 | Form 4 | iRhythm Holdings IRTC | Filing · EDGAR |
| Aug 5, 2025 | Form 144 | iRhythm Holdings IRTC | Filing · EDGAR |
| Jun 13, 2025 | Form 4 | Alphatec Holdings ATEC | Filing · EDGAR |
| Jun 3, 2025 | Form 4 | iRhythm Holdings IRTC | Filing · EDGAR |
| May 6, 2025 | Form 4 | Alphatec Holdings ATEC | Filing · EDGAR |
| Apr 21, 2025 | Form 4 | Paragon 28 FNA | Filing · EDGAR |
| Mar 4, 2025 | Form 4 | iRhythm Holdings IRTC | Filing · EDGAR |
| Feb 27, 2025 | Form 4 | iRhythm Holdings IRTC | Filing · EDGAR |
| Dec 5, 2024 | Form 4 | Alphatec Holdings ATEC | Filing · EDGAR |
| Nov 5, 2024 | Form 4 | iRhythm Holdings IRTC | Filing · EDGAR |
| Jun 14, 2024 | Form 4 | Alphatec Holdings ATEC | Filing · EDGAR |
| May 21, 2024 | Form 4 | Paragon 28 FNA | Filing · EDGAR |
| Mar 8, 2024 | Form 4 | Alphatec Holdings ATEC | Filing · EDGAR |
| Mar 5, 2024 | Form 4 | iRhythm Holdings IRTC | Filing · EDGAR |
| Mar 1, 2024 | Form 4 | iRhythm Holdings IRTC | Filing · EDGAR |
| Feb 29, 2024 | Form 4 | iRhythm Holdings IRTC | Filing · EDGAR |
| Dec 6, 2023 | Form 4/A | iRhythm Holdings IRTC | Filing · EDGAR |
| Jun 21, 2023 | Form 4 | Alphatec Holdings ATEC | Filing · EDGAR |
| Jun 6, 2023 | Form 4 | iRhythm Holdings IRTC | Filing · EDGAR |
| May 19, 2023 | Form 4 | Paragon 28 FNA | Filing · EDGAR |
| Mar 1, 2023 | Form 4 | iRhythm Holdings IRTC | Filing · EDGAR |
| Feb 22, 2023 | Form 3/A | Paragon 28 FNA | Filing · EDGAR |
| Nov 4, 2022 | Form 4 | iRhythm Holdings IRTC | Filing · EDGAR |
| Aug 4, 2022 | Form 4 | Paragon 28 FNA | Filing · EDGAR |
| Aug 4, 2022 | Form 3 | Paragon 28 FNA | Filing · EDGAR |
| Jun 17, 2022 | Form 4 | Alphatec Holdings ATEC | Filing · EDGAR |
| Apr 1, 2022 | Form 4 | Axogen | Filing · EDGAR |
| Oct 7, 2021 | Form 4 | iRhythm Holdings IRTC | Filing · EDGAR |
| Oct 5, 2021 | Form 3 | iRhythm Holdings IRTC | Filing · EDGAR |
| Sep 10, 2021 | Form 4 | Dexcom | Filing · EDGAR |
| Jun 21, 2021 | Form 4 | Alphatec Holdings ATEC | Filing · EDGAR |
| Jun 3, 2021 | Form 4 | Axogen | Filing · EDGAR |
| Jun 1, 2021 | Form 4 | Dexcom | Filing · EDGAR |
| Mar 12, 2021 | Form 4 | Dexcom | Filing · EDGAR |
| Mar 10, 2021 | Form 4 | Dexcom | Filing · EDGAR |
| Jan 26, 2021 | Form 5 | Alphatec Holdings ATEC | Filing · EDGAR |
| Sep 11, 2020 | Form 4 | Dexcom | Filing · EDGAR |
| Sep 8, 2020 | Form 4 | Axogen | Filing · EDGAR |
| Jun 19, 2020 | Form 4 | Alphatec Holdings ATEC | Filing · EDGAR |
| Jun 12, 2020 | Form 4/A | Axogen | Filing · EDGAR |
| Jun 5, 2020 | Form 4/A | Axogen | Filing · EDGAR |
| Jun 3, 2020 | Form 4 | Axogen | Filing · EDGAR |
| Mar 13, 2020 | Form 4 | Dexcom | Filing · EDGAR |
| Mar 10, 2020 | Form 4 | Dexcom | Filing · EDGAR |
| Sep 12, 2019 | Form 4 | Dexcom | Filing · EDGAR |
| Sep 11, 2019 | Form 4 | Dexcom | Filing · EDGAR |
| Sep 5, 2019 | Form 4 | Axogen | Filing · EDGAR |
| Aug 13, 2019 | Form 4 | Axogen | Filing · EDGAR |
| Jun 25, 2019 | Form 4 | Alphatec Holdings ATEC | Filing · EDGAR |
| May 30, 2019 | Form 4 | Dexcom | Filing · EDGAR |
| May 17, 2019 | Form 4 | Axogen | Filing · EDGAR |
| May 6, 2019 | Form 3 | Axogen | Filing · EDGAR |
| Mar 13, 2019 | Form 4 | Dexcom | Filing · EDGAR |
| Mar 11, 2019 | Form 4 | Dexcom | Filing · EDGAR |
| Sep 13, 2018 | Form 4 | Dexcom | Filing · EDGAR |
| Sep 12, 2018 | Form 4 | Dexcom | Filing · EDGAR |
| Aug 1, 2018 | Form 4 | Alphatec Holdings ATEC | Filing · EDGAR |
| Mar 12, 2018 | Form 4 | Dexcom | Filing · EDGAR |
| Dec 29, 2017 | Form 4 | Alphatec Holdings ATEC | Filing · EDGAR |
| Oct 6, 2017 | Form 3 | Alphatec Holdings ATEC | Filing · EDGAR |
| Sep 8, 2017 | Form 4 | Dexcom | Filing · EDGAR |
| Sep 8, 2017 | Form 3 | Dexcom | Filing · EDGAR |
| Feb 10, 2017 | Form 4 | Nuvasive | Filing · EDGAR |
| Feb 3, 2017 | Form 4 | Nuvasive | Filing · EDGAR |
| Jan 4, 2017 | Form 4 | Nuvasive | Filing · EDGAR |
| Jul 5, 2016 | Form 4 | Nuvasive | Filing · EDGAR |
| Feb 3, 2016 | Form 4 | Nuvasive | Filing · EDGAR |
| Jan 28, 2016 | Form 4 | Nuvasive | Filing · EDGAR |
| Jan 5, 2016 | Form 4 | Nuvasive | Filing · EDGAR |
| Dec 7, 2015 | Form 4 | Nuvasive | Filing · EDGAR |
| Oct 5, 2015 | Form 4 | Nuvasive | Filing · EDGAR |
| Jul 6, 2015 | Form 4 | Nuvasive | Filing · EDGAR |
| Apr 8, 2015 | Form 4 | Nuvasive | Filing · EDGAR |
| Jan 5, 2015 | Form 4 | Nuvasive | Filing · EDGAR |
| Nov 20, 2014 | Form 4 | Nuvasive | Filing · EDGAR |
| Aug 8, 2014 | Form 3 | Nuvasive | Filing · EDGAR |
Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.
Data on this page was fetched . The filing on SEC.gov is the record.